Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Carcinoma, Renal Cell 30Neoplasms 11Sarcoma 8Carcinoma, Non-Small-Cell Lung 8Breast Neoplasms 7Ovarian Neoplasms 6Neoplasm Metastasis 5Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Recurrence 2Hemangiosarcoma 2Financial Stress 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Ovarian Epithelial 2Uterine Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Diseases 1Solid Tumours 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Prostatic Neoplasms 1Patient Preference 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms, Plasma Cell 1Melanoma 1Liver Neoplasms 1Leiomyosarcoma 1

Interventions

spartalizumab 2pazopanib 2carotuximab 2belinostat 2balstilimab 2Ipilimumab 2Doxorubicin 2soblidotin 1TTI-621 1Injections 1Imatinib Mesylate 1Ifosfamide 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Hemangiosarcoma × pazopanib × Clear all
NCT01975519 2020-05-20

A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

Tracon Pharmaceuticals Inc.

Phase 1/2 Completed
111 enrolled 15 charts
Sarcoma

Hemangiosarcoma, Sarcoma

NCT02979899 2020-05-12

TAPPAS

Tracon Pharmaceuticals Inc.

Phase 3 Completed
128 enrolled 13 charts
Sarcoma

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡